1. Home
  2. BOC vs ESPR Comparison

BOC vs ESPR Comparison

Compare BOC & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOC
  • ESPR
  • Stock Information
  • Founded
  • BOC 2009
  • ESPR 2008
  • Country
  • BOC United States
  • ESPR United States
  • Employees
  • BOC N/A
  • ESPR N/A
  • Industry
  • BOC
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOC
  • ESPR Health Care
  • Exchange
  • BOC Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • BOC 431.5M
  • ESPR 445.6M
  • IPO Year
  • BOC 2017
  • ESPR 2013
  • Fundamental
  • Price
  • BOC $13.46
  • ESPR $2.83
  • Analyst Decision
  • BOC Buy
  • ESPR Buy
  • Analyst Count
  • BOC 2
  • ESPR 6
  • Target Price
  • BOC $20.00
  • ESPR $6.50
  • AVG Volume (30 Days)
  • BOC 231.5K
  • ESPR 6.0M
  • Earning Date
  • BOC 11-11-2025
  • ESPR 11-06-2025
  • Dividend Yield
  • BOC N/A
  • ESPR N/A
  • EPS Growth
  • BOC N/A
  • ESPR N/A
  • EPS
  • BOC 0.02
  • ESPR N/A
  • Revenue
  • BOC $111,568,551.00
  • ESPR $268,125,000.00
  • Revenue This Year
  • BOC $7.79
  • ESPR $10.59
  • Revenue Next Year
  • BOC $1.77
  • ESPR N/A
  • P/E Ratio
  • BOC $549.36
  • ESPR N/A
  • Revenue Growth
  • BOC 9.53
  • ESPR N/A
  • 52 Week Low
  • BOC $12.27
  • ESPR $0.69
  • 52 Week High
  • BOC $16.20
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • BOC 53.59
  • ESPR 57.17
  • Support Level
  • BOC $13.25
  • ESPR $2.37
  • Resistance Level
  • BOC $13.77
  • ESPR $2.89
  • Average True Range (ATR)
  • BOC 0.24
  • ESPR 0.15
  • MACD
  • BOC -0.70
  • ESPR -0.14
  • Stochastic Oscillator
  • BOC 97.89
  • ESPR 97.24

About BOC Boston Omaha Corporation

Boston Omaha Corp is a United States based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. Company generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: